LivaNova (LIVN) Cost of Revenue (2014 - 2026)
LivaNova (LIVN) posted Cost of Revenue of $1.7 million for Q4 2025, down 98.46% sequentially from $112.9 million in Q3 2025, and down 98.38% YoY from $107.5 million in Q4 2024.
LivaNova (LIVN) Cost of Revenue (2014 - 2026) Analysis & Trends
LivaNova has reported Cost of Revenue for 12 years, with the latest figure at $1.7 million in Q4 2025.
- Quarterly Cost of Revenue fell 98.38% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $116.3 million (down 44.1% YoY) and the FY2025 annual result came in at $365.6 million, down 8.6% from the prior year.
- Cost of Revenue retreated to $1.7 million in Q4 2025 per LIVN's latest filing, from $112.9 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $112.9 million in Q3 2025 and troughed at -$262.3 million in Q4 2023.
- A 5-year average of $58.9 million and a median of $84.4 million in 2021 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2021 and 2023: Cost of Revenue surged 2314.98% in 2021, then plunged 387.15% in 2023.
- Over 5 years, Cost of Revenue stood at $68.4 million in 2021, then jumped by 33.52% to $91.4 million in 2022, then slumped by 387.15% to -$262.3 million in 2023, then jumped by 140.96% to $107.5 million in 2024, then plunged by 98.38% to $1.7 million in 2025.
- According to Business Quant data, Cost of Revenue over the past three periods registered $1.7 million, $112.9 million, and $1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.56 Bn | 126.08 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.09 Bn | 110.87 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 73.80 Bn | 73.26 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.12 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 808.60 Mn |
| 10 | LivaNova | 4.35 Bn | 3.83 Bn | 273.67 Mn | 116.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 116.92 Mn |
| Jun 30, 2026 | 116.92 Mn |
| Mar 31, 2026 | 118.51 Mn |
| Mar 31, 2026 | 118.51 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 112.90 Mn |
| Sep 30, 2025 | 112.90 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 100.60 Mn |
| Mar 31, 2025 | 100.60 Mn |
| Dec 31, 2024 | 107.46 Mn |
| Dec 31, 2024 | 107.46 Mn |
| Mar 31, 2024 | 91.70 Mn |
| Mar 31, 2024 | 91.70 Mn |
| Dec 31, 2023 | -262.33 Mn |
| Dec 31, 2023 | -262.33 Mn |
| Sep 30, 2023 | 84.31 Mn |
| Sep 30, 2023 | 84.31 Mn |